Skip to content

Stock-Based Comp at other companies

Baxter International logo
Baxter InternationalBAX
$10M0.0%
Boston Scientific logo
Boston ScientificBSX
$83M+12.2%
ITG
Integer HoldingsITGR
$6.66M-3.2%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$8.96M-1.3%
Medtronic logo
MedtronicMDT
$95M+6.7%
Abbott logo
AbbottABT
$317M+9.7%

Other financials

Income statement

See full
Revenue$199.4M+25.7%
Gross profit$141.4M+29.4%
Operating income-$16.2M+50.3%
Net income-$13.9M+54.6%
EPS (diluted)-$0.43+55.7%

Balance sheet

See full
Cash & equivalents$248.5M-35.2%
Total debt$79.0M-10.5%
Total equity$161.2M+86.0%
Total assets$1.0B+8.7%

Cash flow

See full
Operating cash flow-$26.2M-232%
CapEx$6.9M-26.7%
Free cash flow-$33.1M-91.1%

Valuation

See full
Market cap$3.62B+16.0%

Profitability

See full
Gross margin71%+1.6pp
Operating margin-5.5%-2.2pp
Net margin-7.3%-3.1pp
FCF margin2.4%

Returns & leverage

See full
Return on equity-53.1%-17.4pp
Debt / equity0.5×-0.5×
Current ratio5.2×-0.5×

Where this comes from

Reported directly by iRhythm Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's stock-based comp?
iRhythm Holdings, Inc. (IRTC) reported stock-based comp of $21.49M in Q1 2026.
How has iRhythm Holdings, Inc. 's stock-based comp changed year-over-year?
iRhythm Holdings, Inc. 's stock-based comp decreased by 7.9% year-over-year, from $23.34M to $21.49M.
What is the long-term trend for iRhythm Holdings, Inc. 's stock-based comp?
Over 4 years (2021 to 2025), iRhythm Holdings, Inc. 's stock-based comp has grown at a 12.8% compound annual growth rate (CAGR), from $54.53M to $88.28M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.